BCR/ABL 210 kD fusion protein 259-269 (HLA-A*03:01) (HLA-A*11:01)

BCR/ABL 210 kD fusion protein 259-269 (HLA-A*03:01) (HLA-A*11:01)
€50.00 *

Prices plus VAT plus shipping costs

Delivery time 3 weeks
sterile and endotoxin free Delivery Format:
The product is supplied freeze dried as trifluoracetate salt

Amount in mg:

make your choice

  • EP11088_1
This peptide has high avidity for CD8 T cells, and can be used in the analysis of individual... more
Product information "BCR/ABL 210 kD fusion protein 259-269 (HLA-A*03:01) (HLA-A*11:01)"
This peptide has high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide composed BCR-ABL 210 kD fusion protein-derived peptide of ATGFKQSSK sequence covering 259-269 and A*03:01, A*11:01 molecule.

 
Sequence:ATGFKQSSK
Gene:BCR
Delivery: 3 weeks
C-Terminus:OH
N-Terminus:H
Purity:95%
Amount:1 mg
Counter Ion:TFA
Protein:Human Bcr-abl 210 kD fusion protein
Species:Human
Allele:HLA-A*03:01 HLA-A*11:01
Application :Flow Cytometry
Indication :Cancer
Viewed